Mycoplasma Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the global Mycoplasma Testing Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Mycoplasma Testing Market Size (2025E): US$ 1.89 Bn
Projected Market Value (2032F): US$ 4.52 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 11.5%

Mycoplasma Testing Market - Report Scope:

The mycoplasma testing market covers a range of diagnostic technologies and products used to detect mycoplasma contamination in cell culture, biopharmaceutical production, and clinical research. These tests are critical in maintaining the quality and safety of biologics, vaccines, and other cell-based products. With the rising demand for biologics and cell therapies, the need for reliable, sensitive, and rapid mycoplasma testing methods is on the rise. Increasing investments in biotechnology and life sciences, along with stringent regulatory norms for contamination control in biomanufacturing, are accelerating the growth of this market.

Market Growth Drivers:

The growth of the global mycoplasma testing market is primarily fueled by the expanding biopharmaceutical sector and the increasing adoption of cell-based technologies in research and manufacturing. Regulatory authorities, including the FDA and EMA, mandate rigorous mycoplasma testing for biologics, which is prompting pharmaceutical companies to invest in advanced testing solutions. The surge in contract research organizations (CROs) and cell banks is also contributing to heightened demand for reliable and efficient mycoplasma detection methods. Furthermore, continuous advancements in PCR and ELISA technologies are enhancing testing sensitivity and reducing turnaround times, further propelling market expansion.

Market Restraints:

Despite strong growth prospects, the mycoplasma testing market faces certain challenges. High costs associated with advanced assay kits and testing systems can be a barrier for smaller laboratories and academic institutions. Additionally, the complexity of testing procedures and the need for specialized equipment and trained personnel may restrict broader adoption in developing regions. Variability in testing outcomes due to sample quality and assay limitations can also affect the reliability of results, raising concerns around test consistency and standardization.

Market Opportunities:

Significant opportunities exist in the mycoplasma testing market due to the increasing focus on personalized medicine, stem cell research, and regenerative therapies. These sectors demand high standards of cell culture integrity, opening new avenues for test providers. Emerging markets in Asia-Pacific and Latin America, which are experiencing growth in biomanufacturing capabilities, present untapped potential for market expansion. Additionally, technological innovations in automated testing platforms and integration of AI-based analysis tools are likely to revolutionize mycoplasma detection, offering faster and more accurate results with reduced human error.

Key Questions Answered in the Report:

What are the primary factors driving the global mycoplasma testing market's growth?
Which technologies and regions are contributing most significantly to market expansion?
How are biopharmaceutical and cell therapy trends influencing the market dynamics?
Who are the leading players in the mycoplasma testing space, and what strategic initiatives are they undertaking?
What emerging innovations could shape the future of the mycoplasma testing industry?

Competitive Intelligence and Business Strategy:

Leading companies in the global mycoplasma testing market, such as Thermo Fisher Scientific, Inc., Lonza Group AG, Merck KGaA, and Charles River Laboratories International, Inc., are prioritizing innovation, quality assurance, and regulatory compliance. These firms are expanding their product portfolios with advanced assays, kits, and reagents while investing in automated platforms for faster processing. Collaborations with biotech firms and academic research centers, along with global distribution networks, are helping them enhance their market presence. Focus on cost-effective solutions and strategic acquisitions further enables them to remain competitive in this rapidly evolving landscape.

Companies Covered in This Report:

Thermo Fisher Scientific, Inc.
Lonza Group AG
Merck KGaA
Charles River Laboratories International, Inc.
PromoCell GmbH
American Type Culture Collection (ATCC)
Asahi Kasei Medical Co., Ltd
Sartorius AG
InvivoGen
Eurofins Scientific

Market Segmentation:

By Technology:

PCR
ELISA
Direct Assay
Microbial Culture

By End-user:

Biopharmaceutical
CROs
Cell Banks

By Product & Service:

Assays
Kits
Reagents

By Region:

North America
Europe
Asia Pacific
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP35400

1. Executive Summary

1.1. Mycoplasma Testing Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Pipeline Analysis
3.3. Product Adoption Analysis
3.4. Value Chain Analysis
3.5. Key Promotional Strategies by Manufacturers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis

4. Mycoplasma Testing Market Outlook:

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Mycoplasma Testing Market Outlook: Technology
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  - 4.3.3.1. PCR
  - 4.3.3.2. ELISA
  - 4.3.3.3. Direct Assay
  - 4.3.3.4. Microbial Culture
- 4.3.4. Market Attractiveness Analysis: Technology
4.4. Global Mycoplasma Testing Market Outlook: End-user
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, End-user, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
  - 4.4.3.1. Biopharmaceutical
  - 4.4.3.2. CROs
  - 4.4.3.3. Cell Banks
- 4.4.4. Market Attractiveness Analysis: End-user
4.5. Global Mycoplasma Testing Market Outlook: Product & Service
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Product & Service, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
  - 4.5.3.1. Assays
  - 4.5.3.2. Kits
  - 4.5.3.3. Reagents
- 4.5.4. Market Attractiveness Analysis: Product & Service

5. Global Mycoplasma Testing Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Mycoplasma Testing Market Outlook:

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Technology
- 6.2.2. By End-user
- 6.2.3. By Product & Service

7. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032

7.1. U.S.
7.2. Canada
7.3. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 7.3.1. PCR
- 7.3.2. ELISA
- 7.3.3. Direct Assay
- 7.3.4. Microbial Culture
7.4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 7.4.1. Biopharmaceutical
- 7.4.2. CROs
- 7.4.3. Cell Banks
7.5. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 7.5.1. Assays
- 7.5.2. Kits
- 7.5.3. Reagents
7.6. Market Attractiveness Analysis

8. Europe Mycoplasma Testing Market Outlook:

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Technology
- 8.2.3. By End-user
- 8.2.4. By Product & Service
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 8.4.1. PCR
- 8.4.2. ELISA
- 8.4.3. Direct Assay
- 8.4.4. Microbial Culture
8.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 8.5.1. Biopharmaceutical
- 8.5.2. CROs
- 8.5.3. Cell Banks
8.6. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 8.6.1. Assays
- 8.6.2. Kits
- 8.6.3. Reagents
8.7. Market Attractiveness Analysis

9. East Asia Mycoplasma Testing Market Outlook:

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Technology
- 9.2.3. By End-user
- 9.2.4. By Product & Service
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 9.4.1. PCR
- 9.4.2. ELISA
- 9.4.3. Direct Assay
- 9.4.4. Microbial Culture
9.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 9.5.1. Biopharmaceutical
- 9.5.2. CROs
- 9.5.3. Cell Banks
9.6. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 9.6.1. Assays
- 9.6.2. Kits
- 9.6.3. Reagents
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Mycoplasma Testing Market Outlook:

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Technology
- 10.2.3. By End-user
- 10.2.4. By Product & Service
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 10.4.1. PCR
- 10.4.2. ELISA
- 10.4.3. Direct Assay
- 10.4.4. Microbial Culture
10.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 10.5.1. Biopharmaceutical
- 10.5.2. CROs
- 10.5.3. Cell Banks
10.6. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 10.6.1. Assays
- 10.6.2. Kits
- 10.6.3. Reagents
10.7. Market Attractiveness Analysis

11. Latin America Mycoplasma Testing Market Outlook:

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Technology
- 11.2.3. By End-user
- 11.2.4. By Product & Service
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 11.4.1. PCR
- 11.4.2. ELISA
- 11.4.3. Direct Assay
- 11.4.4. Microbial Culture
11.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 11.5.1. Biopharmaceutical
- 11.5.2. CROs
- 11.5.3. Cell Banks
11.6. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 11.6.1. Assays
- 11.6.2. Kits
- 11.6.3. Reagents
11.7. Market Attractiveness Analysis

12. Middle East & Africa Mycoplasma Testing Market Outlook:

12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Technology
- 12.2.3. By End-user
- 12.2.4. By Product & Service
12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 12.4.1. PCR
- 12.4.2. ELISA
- 12.4.3. Direct Assay
- 12.4.4. Microbial Culture
12.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 12.5.1. Biopharmaceutical
- 12.5.2. CROs
- 12.5.3. Cell Banks
12.6. Market Size (US$ Bn) Analysis and Forecast, By Product & Service, 2025-2032
- 12.6.1. Assays
- 12.6.2. Kits
- 12.6.3. Reagents
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2025
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Thermo Fisher Scientific, Inc.
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Products
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Lonza Group AG
- 13.3.3. Merck KGaA
- 13.3.4. Charles River Laboratories International, Inc.
- 13.3.5. PromoCell GmbH
- 13.3.6. American Technology Culture Collection
- 13.3.7. Asahi Kasei Medical Co., Ltd.
- 13.3.8. Sartorius AG
- 13.3.9. InvivoGen
- 13.3.10. Eurofins Scientific
- 13.3.11. (ATCC) American Technology Culture Collection

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations

Mycoplasma Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032